Merck said on Thursday its injectable drug for a serious eye disease affecting people with diabetes was as effective as the current standard treatment in improving visual… Reuters Health Information
Category: News
Merck’s Remigromig, a Tri-specific Agonist of the Wingless-related Integration Site (Wnt) Pathway, Met Primary Endpoint in the Pivotal Phase 2b/3 BRUNELLO Study of Adults with Diabetic Macular Edema
RAHWAY, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced topline results from the pivotal Phase 2b/3 BRUNELLO trial in adults with diabetic macular edema (DME). BRUNELLO is the first of two…
Laser Safety: Eye Protection During Aesthetic Treatments
Recommendations from an expert focus on protecting the eyes during laser treatments. Medscape Medical News
Onnuri Smile Eye Clinic’s Patented 1mm SMILE Pro Technology Highlights Safety and Rapid Recovery
SEOUL, South Korea–(BUSINESS WIRE)– #CataractSurgery–Onnuri Smile Eye Clinic, a South Korean ophthalmology clinic, announced its patented 1mm SMILE Pro technique for safer surgery and faster recovery.
Worsening Time in Range Tied to Complications in T1D
Patients with type 1 diabetes whose time in range worsened by 10% or more were over four times as likely to develop microvascular complications as peers with stable control, a 5-year study shows. Medscape Medical News
Beacon’s Gene Therapy for Vision Loss Condition Meets Main Trial Goal
Beacon Therapeutics said on Monday its experimental gene therapy improved the ability to read in low-light conditions in a late-stage trial on people with a form of… Reuters Health Information
Erectile Dysfunction Tied to Higher Odds of Glaucoma
Erectile dysfunction is associated with increased odds of primary open-angle glaucoma in men, a study finds. Medscape Medical News
Kids With Congenital Droopy Eyelids More Likely to Have ADHD
A new study finds nearly 1 in 5 children with congenital ptosis — a condition causing drooping eyelids — are diagnosed with ADHD, a rate far above that seen in the general pediatric population. Medscape Medical News
Science Corporation Names Darius Shahida as President
ALAMEDA, Calif.–(BUSINESS WIRE)–Science Corporation, the neural engineering and brain-computer interface company, today announced the appointment of its Chief Strategy Officer, Darius Shahida, as President, effective immediately. Shahida will continu…
Diabetes Duration, BP Tied to Retinopathy in Youth With T1D
Among children and young people with type 1 diabetes in England, a longer disease duration and higher systolic blood pressure are independently linked to a greater risk for diabetic retinopathy. Medscape News UK
Anti-Inflammatory Meds Tied to Low Diabetic Retinopathy Risk
Patients with type 2 diabetes taking cetirizine, ibuprofen, or prednisone have a lower risk of developing diabetic retinopathy than matched nonusers, a retrospective study shows. Medscape Medical News
Diagnostic Challenges and Clinical Insights of Neurosyphilis
Neurosyphilis, a serious complication of untreated syphilis, can cause irreversible sequelae, including vision loss, hearing loss, and paralysis. Federal Practitioner
Sling Therapeutics Announces First Patients Dosed in Global Phase 3 ORBIT Pivotal Trial of Linsitinib for Thyroid Eye Disease
ANN ARBOR, Mich.–(BUSINESS WIRE)–Sling Therapeutics, Inc., a clinical-stage biopharmaceutical company developing the first and only late-stage oral small-molecule therapy for thyroid eye disease (TED), today announced the first patients have been dos…
Sling Therapeutics Announces $123 Million Series C Financing to Advance Phase 3 Development of its Oral Small Molecule IGF-1R Inhibitor for Thyroid Eye Disease
ANN ARBOR, Mich.–(BUSINESS WIRE)–Sling Therapeutics, Inc., a clinical-stage biopharmaceutical company developing the first and only late-stage oral small-molecule therapy for thyroid eye disease (TED), today announced the close of a $123 million Seri…
Simon Eye Expands Pennsylvania Footprint Through Partnership With Ganly Vision Care
KENNETT SQUARE, Pa.–(BUSINESS WIRE)–Simon Eye Associates (“Simon Eye”), a growing regional provider of comprehensive and advanced eye care, has partnered with Ganly Vision Care in Kennett Square, Pennsylvania, effective September 14, 2026. The partne…
Eyexora to Host Two-Part Key Opinion Leader Webinar Series
NEW YORK & SINGAPORE–(BUSINESS WIRE)–Eyexora, a biotech company pioneering innovative therapies for ophthalmic diseases through a hub-and-spoke model, today announced that it will host a key opinion leader (KOL) webinar series featuring globally reco…
Stuart Therapeutics, Inc. to Present at the Citizens Private Ophthalmology Summit
STUART, Fla.–(BUSINESS WIRE)–Stuart Therapeutics, Inc. (“Stuart”), a late-stage biopharmaceutical company developing a new class of therapeutics designed to repair helical collagen for the treatment of eye diseases, today announced that Eric Schlumpf…
Stem Cells Improve Sight — and Open New Possibilities
People with a progressive genetic eye disorder see more clearly after receiving engineered grafts that repair the damaged surfaces of their eyes, offering a glimpse at what future treatments could hold. Medscape Medical News
Satralizumab Shows Promise for Thyroid Eye Disease
An antibody targeting the interleukin-6 receptor may help reduce bulging of the eyes and inflammation in patients with thyroid eye disease, early phase 3 data show. Medscape Medical News
STAAR Surgical Releases Landmark Global Report Showing Structural Multi-Market Shift Toward Lens-Based Vision Correction
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO™ family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today released a new report entitled The Future of Refr…